Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C16H21NO.BrH |
| Molecular Weight | 324.256 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Br.OC1=CC2=C(C[C@H]3NCC[C@@]24CCCC[C@@H]34)C=C1
InChI
InChIKey=LJAQABDSIONCIU-QALYCTJVSA-N
InChI=1S/C16H21NO.BrH/c18-12-5-4-11-9-15-13-3-1-2-6-16(13,7-8-17-15)14(11)10-12;/h4-5,10,13,15,17-18H,1-3,6-9H2;1H/t13-,15+,16+;/m0./s1
| Molecular Formula | BrH |
| Molecular Weight | 80.912 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C16H21NO |
| Molecular Weight | 243.344 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Effect of methamphetamine on the pharmacokinetics of dextromethorphan and midazolam in rats. | 2005 Jul-Sep |
|
| Validation of a liquid chromatography-mass spectrometry method to assess the metabolism of dextromethorphan in rat everted gut sacs. | 2005 May 5 |
|
| Concise synthesis of dimemorfan (DF) starting from 3-hydroxymorphinan (3-HM). | 2008 Jul |
|
| Inhibitory effect of glutamate release from rat cerebrocortical synaptosomes by dextromethorphan and its metabolite 3-hydroxymorphinan. | 2009 Jul |
|
| A validated SIM GC/MS method for the simultaneous determination of dextromethorphan and its metabolites dextrorphan, 3-methoxymorphinan and 3-hydroxymorphinan in biological matrices and its application to in vitro CYP2D6 and CYP3A4 inhibition study. | 2009 Nov |
|
| Neuropsychotoxic and neuroprotective potentials of dextromethorphan and its analogs. | 2011 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:30:22 GMT 2025
by
admin
on
Mon Mar 31 22:30:22 GMT 2025
|
| Record UNII |
V44B57LQ23
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
V44B57LQ23
Created by
admin on Mon Mar 31 22:30:22 GMT 2025 , Edited by admin on Mon Mar 31 22:30:22 GMT 2025
|
PRIMARY | |||
|
5486108
Created by
admin on Mon Mar 31 22:30:22 GMT 2025 , Edited by admin on Mon Mar 31 22:30:22 GMT 2025
|
PRIMARY | |||
|
63732-85-4
Created by
admin on Mon Mar 31 22:30:22 GMT 2025 , Edited by admin on Mon Mar 31 22:30:22 GMT 2025
|
PRIMARY | |||
|
DTXSID00980237
Created by
admin on Mon Mar 31 22:30:22 GMT 2025 , Edited by admin on Mon Mar 31 22:30:22 GMT 2025
|
PRIMARY | |||
|
m8066
Created by
admin on Mon Mar 31 22:30:22 GMT 2025 , Edited by admin on Mon Mar 31 22:30:22 GMT 2025
|
PRIMARY | Merck Index |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |